25 related articles for article (PubMed ID: 23921761)
1. Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study.
Li W; Zhao X; Wang H; Liu X; Zhao X; Huang M; Qiu L; Zhang W; Chen Z; Guo W; Li J; Zhu X
Oncotarget; 2017 Jun; 8(23):37826-37834. PubMed ID: 27980221
[TBL] [Abstract][Full Text] [Related]
2. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
Kurihara M; Izumi T; Yoshida S; Ohkubo T; Suga S; Kiyohashi A; Yaosaka T; Takahashi H; Ito T; Sasai T
Jpn J Cancer Res; 1991 May; 82(5):613-20. PubMed ID: 1905707
[TBL] [Abstract][Full Text] [Related]
3. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
Saikawa Y; Kubota T; Furukawa T; Suto A; Watanabe M; Kumai K; Ishibiki K; Kitajima M
Jpn J Cancer Res; 1994 Jul; 85(7):762-5. PubMed ID: 8071118
[TBL] [Abstract][Full Text] [Related]
4. A follow-up study on chemoimmunotherapy (5-fluorouracil and BCG) in advanced gastric cancer.
Popiela T; Zembala M; Oszacki J; Jedrychowski W
Cancer Immunol Immunother; 1982; 13(3):182-4. PubMed ID: 6925983
[TBL] [Abstract][Full Text] [Related]
5. Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies.
Narayanan S; de Mores AR; Cohen L; Anwar MM; Lazar F; Hicklen R; Lopez G; Yang P; Bruera E
Curr Oncol Rep; 2023 Jun; 25(6):569-587. PubMed ID: 36995535
[TBL] [Abstract][Full Text] [Related]
6. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis.
Ma Y; Wu X; Yu J; Zhu J; Pen X; Meng X
Oncotarget; 2017 Oct; 8(51):89108-89118. PubMed ID: 29179503
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma.
Guo XF; Yang ZR; Wang J; Lei XF; Lv XG; Dong WG
Mol Med Rep; 2015 Apr; 11(4):2562-8. PubMed ID: 25434307
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival of stomach cancer patients after extensive surgery and adjuvant treatment: an overview of the Japanese experience.
Inokuchi K
Semin Surg Oncol; 1991; 7(6):333-8. PubMed ID: 1759080
[TBL] [Abstract][Full Text] [Related]
9. [Not Available].
Pommer P
Dtsch Med Wochenschr; 2016 Oct; 141(22):1604. PubMed ID: 27824412
[No Abstract] [Full Text] [Related]
10. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Ahn MS; Kang SY; Lee HW; Jeong SH; Park JS; Lee KJ; Cho YK; Han SU; Lee SY; Lim HY; Choi JH
Onkologie; 2013; 36(7-8):421-6. PubMed ID: 23921761
[TBL] [Abstract][Full Text] [Related]
11. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
12. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
13. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205.
Shimada Y; Hamaguchi T; Mizusawa J; Saito N; Kanemitsu Y; Takiguchi N; Ohue M; Kato T; Takii Y; Sato T; Tomita N; Yamaguchi S; Akaike M; Mishima H; Kubo Y; Nakamura K; Fukuda H; Moriya Y
Eur J Cancer; 2014 Sep; 50(13):2231-40. PubMed ID: 24958736
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
15. Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer.
Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M
Cancer Chemother Pharmacol; 1997; 40(3):233-8. PubMed ID: 9219507
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
